Literature DB >> 16585550

Insufficient APC capacities of dendritic cells in gene gun-mediated DNA vaccination.

Henning Lauterbach1, Anton Gruber, Christine Ried, Cedric Cheminay, Thomas Brocker.   

Abstract

Gene gun-mediated DNA immunization is a powerful mode of vaccination against infectious diseases and tumors. Many studies have identified dendritic cells (DC) as the central players in inducing immunity upon biolistic DNA vaccination; however, none of these studies directly quantify DC-mediated responses in comparison with immunity triggered by all Ag- and MHC-expressing cells. In this study we use two different approaches to decipher the relative role of DC vs other cell types in gene gun-induced immunity. First, we directly compared the immunization efficacy of different DNA constructs, which allow Ag expression ubiquitously (CMV promoter) or specifically in DC (CD11c promoter) and would encode either for soluble or membrane bound forms of Ag. Second, we immunized transgenic mice in which only DC can present MHC-restricted Ag, and directly compared the magnitudes of CTL activation with those obtained in wild-type mice. Surprisingly, our combined data suggest that, although DC-specific Ag expression is sufficient to induce humoral responses, DC alone cannot trigger optimal CD4 and CD8 T cell responses upon gene gun vaccination. Therefore, we conclude that DC alone are insufficient to mediate optimal induction of T cell immunity upon gene gun DNA vaccination and that broad Ag expression rather than DC-restricted approaches are necessary for induction of complete immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585550     DOI: 10.4049/jimmunol.176.8.4600

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Genetic targeting of the active transcription factor XBP1s to dendritic cells potentiates vaccine-induced prophylactic and therapeutic antitumor immunity.

Authors:  Shenghe Tian; Zuqiang Liu; Cara Donahue; Louis D Falo; Zhaoyang You
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

2.  Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.

Authors:  Sojung Kim; Adam Zuiani; Javier A Carrero; Ted H Hansen
Journal:  Vaccine       Date:  2012-01-26       Impact factor: 3.641

3.  Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.

Authors:  Stephan Sudowe; Sabine Dominitzki; Evelyn Montermann; Matthias Bros; Stephan Grabbe; Angelika B Reske-Kunz
Journal:  Immunology       Date:  2008-09-17       Impact factor: 7.397

4.  Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.

Authors:  Guixiang Dai; Hamada F Rady; Weitao Huang; Judd E Shellito; Carol Mason; Alistair J Ramsay
Journal:  Vaccine       Date:  2016-11-04       Impact factor: 3.641

5.  Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responses.

Authors:  Viswa Teja Colluru; Christopher D Zahm; Douglas G McNeel
Journal:  Oncoimmunology       Date:  2016-09-02       Impact factor: 8.110

6.  Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.

Authors:  Victor C Huber; Raelene M McKeon; Martha N Brackin; Laura A Miller; Rachael Keating; Scott A Brown; Natalia Makarova; Daniel R Perez; Gene H Macdonald; Jonathan A McCullers
Journal:  Clin Vaccine Immunol       Date:  2006-09

Review 7.  Basic and translational applications of engineered MHC class I proteins.

Authors:  Ted H Hansen; Janet M Connolly; Keith G Gould; Daved H Fremont
Journal:  Trends Immunol       Date:  2010-09-09       Impact factor: 16.687

8.  HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo.

Authors:  Cecele J Denman; James McCracken; Vidhya Hariharan; Jared Klarquist; Kepa Oyarbide-Valencia; José A Guevara-Patiño; I Caroline Le Poole
Journal:  J Invest Dermatol       Date:  2008-03-13       Impact factor: 8.551

9.  Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides.

Authors:  Steven M Truscott; Xiaoli Wang; Lonnie Lybarger; William E Biddison; Cortez McBerry; John M Martinko; Janet M Connolly; Gerald P Linette; Daved H Fremont; Ted H Hansen; Beatriz M Carreno
Journal:  J Biol Chem       Date:  2008-01-14       Impact factor: 5.157

10.  Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Listeria vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming.

Authors:  Laura E Johnson; Dirk Brockstedt; Meredith Leong; Peter Lauer; Erin Theisen; John-Demian Sauer; Douglas G McNeel
Journal:  Oncoimmunology       Date:  2018-05-07       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.